Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.

Xu XH, Zhong Z.

Acta Pharmacol Sin. 2013 Jun;34(6):755-64. doi: 10.1038/aps.2013.63. Epub 2013 May 20. Review.

2.

Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Grskovic M, Javaherian A, Strulovici B, Daley GQ.

Nat Rev Drug Discov. 2011 Nov 11;10(12):915-29. doi: 10.1038/nrd3577. Review.

PMID:
22076509
3.

Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

Marchetto MC, Brennand KJ, Boyer LF, Gage FH.

Hum Mol Genet. 2011 Oct 15;20(R2):R109-15. doi: 10.1093/hmg/ddr336. Epub 2011 Aug 9. Review.

4.

iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery.

Zhang R, Zhang LH, Xie X.

Acta Pharmacol Sin. 2013 Jun;34(6):765-76. doi: 10.1038/aps.2013.21. Epub 2013 Apr 22. Review.

5.

Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.

Corti S, Faravelli I, Cardano M, Conti L.

Expert Opin Drug Discov. 2015 Jun;10(6):615-29. doi: 10.1517/17460441.2015.1037737. Epub 2015 Apr 20. Review.

PMID:
25891144
6.

A new era of disease modeling and drug discovery using induced pluripotent stem cells.

Suh W.

Arch Pharm Res. 2017 Jan;40(1):1-12. doi: 10.1007/s12272-016-0871-0. Epub 2016 Dec 5. Review.

PMID:
27921262
7.

New lessons learned from disease modeling with induced pluripotent stem cells.

Onder TT, Daley GQ.

Curr Opin Genet Dev. 2012 Oct;22(5):500-8. doi: 10.1016/j.gde.2012.05.005. Epub 2012 Jun 28. Review.

8.

Induced pluripotent stem cells as a disease modeling and drug screening platform.

Ebert AD, Liang P, Wu JC.

J Cardiovasc Pharmacol. 2012 Oct;60(4):408-16. doi: 10.1097/FJC.0b013e318247f642. Review.

9.

Concise review: drug discovery in the age of the induced pluripotent stem cell.

Ko HC, Gelb BD.

Stem Cells Transl Med. 2014 Apr;3(4):500-9. doi: 10.5966/sctm.2013-0162. Epub 2014 Feb 3. Review.

10.

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.

Jang J, Yoo JE, Lee JA, Lee DR, Kim JY, Huh YJ, Kim DS, Park CY, Hwang DY, Kim HS, Kang HC, Kim DW.

Exp Mol Med. 2012 Mar 31;44(3):202-13. doi: 10.3858/emm.2012.44.3.015.

11.

Accelerating progress in induced pluripotent stem cell research for neurological diseases.

Ito D, Okano H, Suzuki N.

Ann Neurol. 2012 Aug;72(2):167-74. doi: 10.1002/ana.23596. Review.

PMID:
22926850
12.

Concise review: modeling central nervous system diseases using induced pluripotent stem cells.

Zeng X, Hunsberger JG, Simeonov A, Malik N, Pei Y, Rao M.

Stem Cells Transl Med. 2014 Dec;3(12):1418-28. doi: 10.5966/sctm.2014-0102. Epub 2014 Nov 3. Review.

13.

Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.

Kawser Hossain M, Abdal Dayem A, Han J, Kumar Saha S, Yang GM, Choi HY, Cho SG.

Int J Mol Sci. 2016 Feb 19;17(2):256. doi: 10.3390/ijms17020256. Review.

14.

Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.

Nsair A, MacLellan WR.

Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):324-30. doi: 10.1016/j.addr.2011.01.013. Epub 2011 Mar 1. Review.

15.

Can cellular models revolutionize drug discovery in Parkinson's disease?

Schüle B, Pera RA, Langston JW.

Biochim Biophys Acta. 2009 Nov;1792(11):1043-51. doi: 10.1016/j.bbadis.2009.08.014. Epub 2009 Sep 3. Review.

16.

Modeling human neurological disorders with induced pluripotent stem cells.

Imaizumi Y, Okano H.

J Neurochem. 2014 May;129(3):388-99. doi: 10.1111/jnc.12625. Epub 2013 Dec 15. Review.

17.
18.

Human stem cells and drug screening: opportunities and challenges.

Ebert AD, Svendsen CN.

Nat Rev Drug Discov. 2010 May;9(5):367-72. doi: 10.1038/nrd3000. Epub 2010 Mar 26. Review.

PMID:
20339370
19.

Pluripotent stem cell for modeling neurological diseases.

Yung JS, Tam PK, Ngan ES.

Exp Cell Res. 2013 Jan 15;319(2):177-84. doi: 10.1016/j.yexcr.2012.11.007. Epub 2012 Nov 15. Review.

PMID:
23159386
20.

Induced pluripotent stem cells to model and treat neurogenetic disorders.

Wang H, Doering LC.

Neural Plast. 2012;2012:346053. doi: 10.1155/2012/346053. Epub 2012 Jul 19. Review.

Supplemental Content

Support Center